EASL Studio S2 E18: How can our response to the climate crisis transform and improve hepatology services?

EASL Studio S2 E17: EASL Haemochromatosis Guidelines 2022

EASL Studio S2 E16: The NAFLD pandemic

EASL Studio S2 E15: JHEP Live on the best animal model for HCC – Lost in translation?

EASL Studio S2 E14: Elastography – The new non-invasive gold standard in portal hypertension?

EASL Studio Special Edition: Unexplained acute hepatitis in children

EASL Studio S2 E13: Digital Pathology

EASL Studio S2 E12: Nurse and AHP Focus: Sustainable hepatology – Insights in nursing initiatives

EASL Studio S2 E11: JHEP Live: Stop Nuc in HBeAg negative patients

EASL Studio S2 E10: LITMUS: Defining the colour of NAFLD

EASL Studio S2 E9: YI Choice: Propelling liver cell biology into the third dimension

EASL Studio S2 E8: Treatment of HBV-HDV coinfection in the era of entry inhibition

EASL Studio S2 E7: JHEP Live on critical appraisal of classification, diagnosis and treatment of hepatic encephalopathy

EASL Studio S2 E6: Should anticoagulants be given to patients with cirrhosis to improve outcome?

EASL Studio S2 E5: New era for science dissemination: The role of social media

EASL Studio S2 E4: Betablockers in cirrhosis: Has Baveno consensus gone too far?

EASL Studio S2 E3: Interview with Stephan Urban - From bench to bedside: Process of developing the first HBV/HDV entry inhibitor

EASL Studio S2 E2: Fats or carbs, who is the real villain?

EASL Studio Special Edition: Live from Viral Hepatitis Elimination Conference 2022

EASL Studio S2 E1: New treatment options for hereditary cholestasis syndromes: A game-changer?